0001720959-19-000003.txt : 20191115 0001720959-19-000003.hdr.sgml : 20191115 20191115141626 ACCESSION NUMBER: 0001720959-19-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191115 DATE AS OF CHANGE: 20191115 EFFECTIVENESS DATE: 20191115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neumentum, Inc. CENTRAL INDEX KEY: 0001720959 IRS NUMBER: 821679493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-353545 FILM NUMBER: 191223759 BUSINESS ADDRESS: STREET 1: 252 COLORADO AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 9082396142 MAIL ADDRESS: STREET 1: 252 COLORADO AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 D 1 primary_doc.xml X0708 D LIVE 0001720959 Neumentum, Inc. 252 COLORADO AVENUE PALO ALTO CA CALIFORNIA 94301 908-239-6142 DELAWARE None None Corporation true 2017 Richard Scott Shively c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Executive Officer Joseph Pergolizzi c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Director Christine Cvijic c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Executive Officer Director Pedro Granadillo c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Director Ilona Steigerwald c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Executive Officer August Moretti c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Director Pharmaceuticals Decline to Disclose 06b false 2019-11-01 false true true false 0 CIM Securities, LLC 120852 None None 509 Madison Avenue Suite 906 New York NY NEW YORK 10022 CA CALIFORNIA KY KENTUCKY NY NEW YORK TX TEXAS false Arcadia Securities, LLC 44656 None None 1370 AVENUE OF THE AMERICAS 29TH FL New York NY NEW YORK 10019 AK ALASKA AR ARKANSAS FL FLORIDA NV NEVADA NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA OH OHIO TX TEXAS UT UTAH false 7000000 2663000 4337000 false 18 420000 true 0 Commissions are a % of the total offering. Agent shall also receive a 7 yr warrant for 7% of the number of shares into which securities sold in the offering convert (or, a cash fee of 7% of the purchase price for the securities.) 660000 true The amount reflected in this Item 16 includes only salary and consulting payments the Issuer anticipates making to the executive officers and certain directors listed in Item 3, and assumes the Company raises the entire $7MM. false Neumentum, Inc. /s/ Scott Shively Scott Shively Cheif Executive Officer 2019-11-15